The purpose is to understand the clinical characteristics of chronic heart failure as soon as possible, analyze the etiology, comorbidities, clinical characteristics, and treatment of heart failure patients, observe the gap between real-world clinical practice and guideline recommendations, and provide reference for the improvement of heart failure prevention and treatment in China.
Inclusion criteria: 1. Accompanied by difficulty breathing, fatigue, or decreased activity tolerance; 2. Signs of fluid retention (pulmonary congestion and peripheral edema); 3. Echocardiography shows abnormalities in cardiac structure and/or function; 4. Elevated levels of natriuretic peptide: B-type natriuretic peptide (BNP)\>35 ng/L and/or N-terminal B-type proBNP (NT proBNP)\>125 ng/L. 5. HF hospitalization recorded within the previous 12 months Exclusion criteria: 1. Concomitant severe liver function, renal failure, or other severe system dysfunction 2. Poor compliance, inability to obtain information, or voluntary refusal to participate in this study.
Study Type
OBSERVATIONAL
Enrollment
20,000
no intervention
echocardiogram
ejection fraction,Consider heart failure when the ejection fraction is less than 50%
Time frame: Follow up will be conducted at baseline, 6 months, 12 months, and 36 months
cardiac marker
CK，CK-MB，cTnT，cTnI，Mb
Time frame: Follow up will be conducted at baseline, 6 months, 12 months, and 36 months
serum biochemical indicators
HDL-cholesterol, mg/dL，LDL-cholesterol, mg/dL，Total cholesterol, mg/dL，Triglycerides, mg/dL
Time frame: Follow up will be conducted at baseline, 6 months, 12 months, and 36 months
Thyroid Function
thyroid hormone,Thyroid hormone blood testing: This is the most commonly used method to measure thyroid hormone levels in the blood. Common thyroid hormone indicators include thyroxine, free thyroxine, triiodothyronine, and free triiodothyronine.
Time frame: Follow up will be conducted at baseline, 6 months, 12 months, and 36 months
Coagulation function indicators
D-Dimer
Time frame: Follow up will be conducted at baseline, 6 months, 12 months, and 36 months
Blood routine
RBC
Time frame: Follow up will be conducted at baseline, 6 months, 12 months, and 36 months
Blood routine
WBC
Time frame: Follow up will be conducted at baseline, 6 months, 12 months, and 36 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Blood routine
PLT
Time frame: Follow up will be conducted at baseline, 6 months, 12 months, and 36 months